🇺🇸 FDA
Pipeline program

Placebo to OXYMETAZOLINE HYDROCHLORIDE (Vehicle), STN1013800

101380003SA

Phase 3 small_molecule active

Quick answer

Placebo to OXYMETAZOLINE HYDROCHLORIDE (Vehicle), STN1013800 for Acquired Blepharoptosis is a Phase 3 program (small_molecule) at Santen Oy with 1 ClinicalTrials.gov record(s).

Program details

Company
Santen Oy
Indication
Acquired Blepharoptosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials